Nicole Thomas, BSc^1*, Kostiantyn Dreval^1*, Daniela S. Gerhard, Ph.D.^2*, Laura K Hilton, PhD^3*, Jeremy S. Abramson, MD⁴, Nancy L. Bartlett, MD⁵, Jeffrey Bethony, PhD^6*, Jay Bowen, MS^7*, Anthony Bryan^7*, Corey Casper, MD, MPH^8*, Maureen Dyer, PhD^9*, Manel Esteller, MD, PhD^10*, Carlos Garcia-Prieto^10*, Julie M Gastier-Foster, PhD¹¹, Alina S. Gerrie, MD, MPH, FRCPC³, Bruno M. Grande, PhD^12*, Timothy C. Greiner, MS, MD¹³, Nicholas B. Griner, PhD^2*, Thomas G. Gross, MD, PhD¹⁴, Nancy Lee Harris, MD¹⁵, John D. Irvin, MD, PhD^16*, Elaine S. Jaffe, MD¹⁷, Fabio Leal, MD, PhD^18*, Jean Paul Martin, PhD^16*, Marie-Reine Martin, MD^16*, Sam M. Mbulaiteye, MBBChir, MPhil^19*, Charles G. Mullighan, MBBS, MD²⁰, Andrew J. Mungall, PhD^21*, Karen Mungall, PhD^21*, Constance Namirembe^22*, Ariela Noy, MD²³, Martin D Ogwang^24*, Jackson Orem, MBChB, MMed, PhD²², German Ott, Prof.^25*, Hilary Petrello^7*, Steven J Reynolds^26*, Steven H. Swerdlow, MD²⁷, Alexandra Traverse-Glehen^28*, Wyndham H. Wilson, MD, PhD²⁹, Marco A. Marra^21,30, Louis M. Staudt, MD, PhD²⁹, David W. Scott, PhD, MD, FRACP, FRCPA³ and Ryan D. Morin^3,21,31

¹Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, BC, Canada
²Office of Cancer Genomics, National Cancer Institute, Bethesda, MD
³Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁴Center for Lymphoma, Massachusetts General Hospital, Boston, MA
⁵Washington University School of Medicine, St. Louis, MO
⁶George Washington University, Washington, DC
⁷Biopathology Center, Nationwide Children's Hospital, Columbus, OH
⁸Access to Advanced Health Institute, Seattle, WA
⁹Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD
¹⁰Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain
¹¹Department of Pathology and Laboratory Medicine, Nationwide Children’s Hospital and Ohio State University, Columbus, OH
¹²Sage Bionetworks, Seattle, WA
¹³Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
¹⁴Center for Global Health, National Cancer Institute, NIH, Rockville, MD
¹⁵Department of Pathology, Massachusetts General Hospital, Boston, MA
¹⁶Foundation for Burkitt Lymphoma Research, Geneva, Switzerland
¹⁷Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹⁸Programa de Oncovirologia, Instituto Nacional de Cancer, Rio de Janeiro, Brazil
¹⁹Division of Cancer Epidemiology and Genetics, National Cancer Institute, Silver Spring, MD
²⁰Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
²¹Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada
²²Uganda Cancer Institute, Kampala, Uganda
²³Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²⁴St. Mary’s Hospital, Gulu, Uganda
²⁵Department of Clinical Pathology, Robert-bosch-Krankenhaus; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, DEU
²⁶National Institute of Allergy and Infectious Diseases, Bethesda, MD
²⁷Division of Hematopathology, UPMC, Pittsburgh, PA
²⁸Service d'Anatomie pathologique, Université Lyon 1/Centre Hospitalier Lyon Sud, Pierre Bénite, France
²⁹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³⁰Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
³¹Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada

Yuta Ito^1,2*, Amira Marouf^3*, Yasunori Kogure, MD, PhD^1*, Junji Koya, MD, PhD^1*, Mariko Tabata, MD^1,4*, Yuki Saito, MD, PhD^1,5*, Sumito Shingaki, MD, PhD^1*, Mitsuhiro Yuasa, MD^1,6*, Kentaro Yamaguchi, MD^1,7*, Julie Bruneau, MD, PhD^3,8*, Manon Vavasseur^3*, Michaël Dussiot, PhD^3*, Isabelle Andre, PhD^9*, Akshay Joshi^9*, Chantal Lagresle-Peyrou^9*, Aude Magerus^10*, Sammara Chaubard^11*, David Lavergne, PhD^11*, Emmanuel Bachy, MD, PhD^12*, Erika Brunet, PhD^13*, Virginie Fataccioli, PhD^14*, Chantal Brouzes, MD^15,16*, Camille Laurent, MD, PhD^17*, Laurence De Leval, MD¹⁸, Alexandra Traverse-Glehen^19*, Céline Bossard^20*, Marie Parrens, MD, PhD^21*, Véronique Meignin^22*, Laure Philippe, MD^23*, Julien Rossignol^3,24*, Felipe Suarez, MD, PhD^3,24, Jean-Marie Michot, MD^25*, Olivier Tournilhac, MD, PhD^26*, Christine Bole-Feysot, PhD^27*, Patrick Nitschke^28*, Bruno Tesson^29*, Cécile Laurent^29*, Thierry Jo Molina, MD, PhD^3,8*, Vahid Asnafi, MD, PhD^15,16*, Sachiko Tsukita^30*, Koji Izutsu^31,32*, Hiroaki Miyoshi, MD, PhD^33*, Seiji Sakata^34,35,36*, Akito Dobashi^34,35,36*, Kengo Takeuchi^34,35,36*, Koichi Ohshima, MD, PhD^33*, Philippe Gaulard, MD, PhD^14*, Arnaud Jaccard^11*, Seishi Ogawa, MD, PhD^37,38, Olivier Hermine, MD, PhD^3,24, Keisuke Kataoka, MD, PhD^1,7 and Lucile Couronne^3,15*

¹Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan
²Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
³Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications, INSERM U1163, Imagine Institute, Paris City University, Paris, France
⁴Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
⁵Department of Gastroenterology, Keio University School of Medicine, Tokyo, Japan
⁶Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
⁷Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
⁸Pathology Department, Necker Children's Hospital, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
⁹Laboratory of Human Lympho Hematopoiesis, INSERM UMR 1163, Clinical Investigation Center (CIC) 1416-Institut Imagine, Paris City University, Paris, France
¹⁰Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris City University, Paris, France
¹¹Hematology department, Limoges University Hospital, Limoges, France
¹²Hematology Department, Hospices Civils de Lyon; Lymphoma Immuno-Biology (LIB) Team, Université Claude Bernard Lyon 1, Lyon, France
¹³Laboratory of the « Genome Dynamics in the Immune System », Équipe Labellisée La Ligue Contre Le Cancer, Paris City University, Université Paris Saclay, INSERM UMR 1163, Institut Imagine, Paris, Falkland Islands (The) [Malvinas]
¹⁴Pathology Department, Henri Mondor University Hospital, Assistance Publique des Hôpitaux de Paris, INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Créteil University, Créteil, France
¹⁵Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
¹⁶INSERM U1151, Institut Necker Enfants Malades (INEM), Paris, France
¹⁷Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France; Cancer Research Center of Toulouse, INSERM UMR 1037, ERL5294 CNRS, Université Toulouse III-Paul-Sabatier, Toulouse, France
¹⁸Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland
¹⁹Department of Pathology, Centre Hospitalier Lyon Sud and Université Claude Bernard Lyon-1, Pierre- Bénite, France
²⁰Department of Pathology, CHU Nantes, Nantes, France; Université de Nantes, INSERM CRCINA, Nantes, France
²¹Department of Pathology, Bordeaux University Hospital, Bordeaux, France
²²Pathology Department, Hôpital Saint Louis, Paris City University, Paris, France
²³Department of Hematology, CH Annecy Genevois, Metz-Tessy, France
²⁴Hematology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France
²⁵Gustave Roussy, Département des Innovations Thérapeutiques et Essais Précoces, Université Paris-Saclay, Villejuif, France
²⁶Department of Hematology, University Hospital of Clermont-Ferrand, Clermont Auvergne University, Clermont-Ferrand, France
²⁷Genomics Core Facility, Institut Imagine-Structure Fédérative de Recherche Necker, INSERM U1163 et INSERM US24/CNRS UAR3633, Paris City University, Paris, France
²⁸INSERM Unité Mixte de Recherche 1163, Bioinformatics Platform, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France
²⁹Bioinformatics department, CALYM / LYSARC, Paris, France
³⁰Advanced Comprehensive Research Organization (ACRO), Teikyo University, Toko, Japan
³¹National Cancer Center Hospital, Tokyo, Japan
³²Department of Hematology, Toranomon Hospital, Tokyo, Japan
³³Department of Pathology, Kurume University School of Medicine, Kurume, Japan
³⁴Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
³⁵Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
³⁶Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
³⁷Center for Hematology and Regenerative Medicine, Department of Medicine (MedH), Karolinska Institutet, Huddinge, Sweden
³⁸Department of Pathology and Tumor Biology, Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan

Zachary R Hunter, PhD¹, Nickolas Tsakmaklis^1*, Kris Richardson, PhD^1*, Maria Luisa Guerrera, MD^1*, Amanda Kofides^1*, Xia Liu, MD^1*, Shirong Liu, MD PhD^1*, Alexa Canning^1*, Manit Munshi, MS^1*, Shayna Sarosiek, MD¹, Catherine A. Flynn, NP^1*, Andrew R. Branagan, MD², Lian Xu, MS^1*, Guang Yang, PhD¹, Kirsten Meid, MPH^1*, Joshua Gustine, MPH^1*, Christopher J Patterson, MS, MPH^1*, Kenneth C. Anderson, MD³, Nikhil C Munshi, MD, PhD³, Jorge J. Castillo, MD¹ and Steven P Treon, MD, PhD¹

¹Bing Center for Waldenstrom's macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
²Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA
³Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA

Kerstin Wenzl, PhD¹, Matthew E Stokes, PhD^2*, Joseph P. Novak^1*, Sana Khan^1*, Melissa A. Hopper, BS, MS¹, Jordan E. Krull¹, Abigail Dropik^1*, Vivekananda Sarangi^3*, Raphael Mwangi, MS^4*, Maria Ortiz, PhD^5*, Nicholas Stong, PhD^2*, C. Chris Huang, PhD^6*, Matthew J. Maurer, DSc⁴, Lisa M. Rimsza, MD⁷, Brian K. Link, MD⁸, Susan L. Slager, PhD⁴, Yan Asmann, PhD⁹, Patrizia Mondello, MD, PhD, MSc¹, Ryan D. Morin¹⁰, Stephen M. Ansell, MD, PhD¹, Thomas M. Habermann, MD¹¹, Andrew L. Feldman, MD¹², Rebecca L. King, MD¹³, Grzegorz S. Nowakowski, MD¹, James R. Cerhan, MD, PhD⁴, Anita K. Gandhi, PhD⁶ and Anne J. Novak, PhD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, NJ
³Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁴Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN
⁵Informatics and Predictive Sciences, Bristol Myers Squibb, Seville, Spain
⁶Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ
⁷Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ
⁸Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
⁹Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL
¹⁰Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada
¹¹Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
¹²Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
¹³Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Beatriz García-Torre^1*, Marta Kulis, PhD^1*, Mònica Romo^1*, Anna Vidal, PhD^1*, Stella Charalampopoulou^1*, Vicente Chapaprieta^1*, Martí Duran-Ferrer^1,2*, Ferran Nadeu, PhD^1,2*, Cristina López, PhD^1,2*, Guillem Clot, PhD^1,2*, Eva Giné, MD, PhD^1,2,3, Armando Lopez-Guillermo, MD^1,2,3, Sílvia Beà, PhD^3,4,5,6*, Dolors Colomer, PhD^2,3,6,7*, Elías Campo, PhD MD^2,3,8,9 and José I. Martín-Subero, PhD^1,2,9,10*

¹Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
²Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
³Hospital Clínic de Barcelona, Barcelona, Spain
⁴Molecular Pathology of Lymphoid Neoplasms Group, IDIBAPS, Barcelona, Spain
⁵Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain
⁶University of Barcelona, Barcelona, Spain
⁷Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
⁸IDIBAPS, Barcelona, Spain
⁹Universitat de Barcelona, Barcelona, Spain
¹⁰Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

Krysta M. Coyle, PhD¹, Qurat Ul Ain Qureshi, BSc^2*, Balwinder Ruprai, BSc^2*, Tejdeep Kang^2*, Laura K Hilton, PhD^3*, Kostiantyn Dreval, PhD^2,4*, Prasath Pararajalingam, BSc^2*, Christopher K Rushton^2*, Nicole Thomas², Timothy E Audas, PhD^2* and Ryan D. Morin^4,5

¹Department of Molecular Biology & Biochemistry, Simon Fraser University, Vancouver, BC, Canada
²Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, BC, Canada
³Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, BC, Canada
⁴Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada
⁵Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada